After the FDA removed semaglutide injection products from a shortage list, compounders like Hims have 60-90 days to stop ...

Hims & Hers delivered Q4 2024 earnings that saw the stock sell off nearly 20% after hours. Find out why I rate HIMS stock a ...

Hims & Hers dipped 19% post-Q4 earnings. Read here for HIMS stock's growth trends, margin concerns, and why this could be a ...

There’s something about pot roast that feels like home. It’s warm, hearty and comforting—the kind of meal that brings ...

After closing at a record high of 57,703 on 11 December 2024, the BSE SmallCap index has tumbled to 45,157 in just over two ...

A cash advocate has torn into comments from the Reserve Bank of Australia’s Governor Michele Bullock, who predicted Aussies would not be using cash in about 10 years.

Hims & Hers Health (HIMS) has seen its shares decline over 17% in the past week since the U.S. Food and Drug Administration (FDA) announced ...

Hims & Hers Health Inc. shares plunged over 18% in after-hours trading on Monday after the telehealth company reported strong ...

Telehealth and wellness platform Hims & Hers on Monday offered a revenue outlook for the year ahead that topped Wall Street’s ...

ETFS like the Vanguard FTSE Emerging Markets All Cap Index ETF (TSX:VEE) can maximize your TFSA wealth.

John was raised for the livestock show by Aniston Floyd from the Denver City, Texas Future Farmers of America program.

Hims shares have roughly doubled since the start of the year, despite the FDA’s announcement last week that Novo Nordisk’s ...